ストックスクリーナーアプリを入手
5.99
2.92%
-0.18
アフターアワーズ：
5.73
-0.26
-4.34%
Nextcure Inc (NXTC) 最新ニュース
NextCure Inc. (NXTC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
NextCure and Avere Therapeutics Announce Merger and $320 Million Private Financing - Global Legal Chronicle
NextCure (NASDAQ: NXTC) details Avere merger structure and S-4 plan - Stock Titan
NextCure (NXTC) Slides As Avere Merger Triggers Legal Scrutiny - StocksToTrade
H.C. Wainwright reiterates NextCure stock rating on merger news - Investing.com
H.C. Wainwright reiterates NextCure stock rating on merger news By Investing.com - Investing.com UK
Beltsville's NextCure merging with San Francisco startup - The Business Journals
Dow Falls Over 100 Points Following Inflation Data; Crude Oil Gains - Sahm
NextCure Announces Transformative All-Stock Merger With Avere - TipRanks
NextCure, Avere Therapeutics enter definitive merger agreement - TipRanks
Law firm investigates if NextCure shareholders get a fair price in merger with Avere Therapeutics. - Pluang
NXTC Stock Alert: Halper Sadeh LLC is Investigating Whether NextCure, Inc. is Obtaining a Fair Price for its Shareholders - GlobeNewswire Inc.
Avere, NextCure Merge To Take AVR-001 Ahead In Psoriasis, Ulcerative Colitis - insights.citeline.com
After $5 billion-plus Novo Nordisk buyout, this biotech band is playing an encore with big merger plans - The Business Journals
Power Moves: NXTC, TOON, SHPH, COCH Entry Points Ignite on Major Catalysts - FinancialContent
Why Did NextCure Stock 3X In One Session?NextCure (NASDAQ:NXTC) - Benzinga
Law firm investigates NextCure merger fairness as shareholders get 1.21% stake in combined company - Pluang
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of NextCure, Inc. (NASDAQ: NXTC) - PR Newswire
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
NextCure, Inc. (NXTC) Stock: Soars 218% After Avere Merger and $320M Private Placement Deal - parameter.io
NextCure stock surge puts cash payout and 1.21% Avere stake under the lens - TechStock²
NextCure faces investigation over merger terms with Avere Therapeutics amid shareholder concerns. - Pluang
NextCure and Avere Therapeutics Announce $320M Merger to Advance Once-Weekly Oral IL-23 Therapy for Psoriasis and Ulcerative Colitis 12 – Minichart - Minichart
Shareholder Alert: Ademi LLP investigates whether NextCure, Inc. is obtaining a Fair Price for Public Shareholders - PR Newswire
NXTC Stock Alert: Halper Sadeh LLC is Investigating Whether NextCure, Inc. is Obtaining a Fair Price for its Shareholders - Business Wire
NextCure skyrockets on Avere reverse-merger deal and $320 million financing plan - Quiver Quantitative
NextCure backs Avere merger with $320 million financing - grafa.com
Avery Therapeutics, Inc. entered into a definitive merger agreement to acquire NextCure, Inc. for $250 million in a reverse merger transaction. - marketscreener.com
NXTC Stock Rockets On Massive Volume As Traders Pile In - StocksToTrade
NextCure to merge with Avere Therapeutics in $320M deal By Investing.com - Investing.com Australia
NextCure (NXTC) Stock Skyrockets 300% Following $320M Avere Therapeutics Merger Agreement - parameter.io
NextCure (NXTC) Stock Rockets 300% Following $320M Avere Therapeutics Merger Announcement - MoneyCheck
NextCure (NXTC) Stock Skyrockets 300% Following $320 Million Avere Therapeutics Merger Agreement - Blockonomi
NextCure (NXTC) Stock Surges 300% on $320M Merger Deal With Avere Therapeutics - CoinCentral
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
NextCure and Avere Therapeutics Merge, Raise $320 Million to Advance Oral IL-23 Program - citybiz
Fresh off buyout, Akero execs reunite to advance long-acting psoriasis pill - Yahoo Finance
NextCure to merge with privately-held Avere (NXTC:NASDAQ) - Seeking Alpha
NextCure (NASDAQ: NXTC) plans reverse merger; Avere holders to own about 98% - Stock Titan
NextCure to Merge With Avere in Stock Deal; $320 Million PIPE to Fund Combined Company - TradingView
NextCure (NASDAQ: NXTC) sets Avere merger backed by $320M raise - Stock Titan
NextCure to merge with Avere Therapeutics in $320M deal - Investing.com
NextCure and Avere Therapeutics Announce Definitive Merger and $320 Million Financing to Advance Oral IL-23 Therapy AVR-001 - Quiver Quantitative
NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy - The Manila Times
After $4.7B sale to Novo Nordisk, former Akero team announces new I&I company with China drug - Endpoints News
What's going on with NextCure stock Wednesday? - MSN
Price to sales forward of NextCure, Inc. – NASDAQ:NXTC - TradingView
Price to sales forward of NextCure, Inc. – LSX:A41AKJ - TradingView
Enterprise value to EBITDA forward of NextCure, Inc. – NASDAQ:NXTC - TradingView
Enterprise value to EBITDA forward of NextCure, Inc. – MUN:2US0 - TradingView
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
NextCure Company Profile & Introduction - Moomoo
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
NextCure (NXTC) H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference summary - Quartr
NXTCNextcure Inc Options - Finviz
NextCure Inc. (NXTC) Q1 2026 Earnings: EPS Beat Mitigates Losses Amid Ongoing Clinical DevelopmentEarnings Forecast Report - dars.gov.et
NextCure, Inc.(NasdaqGS: NXTC) added to Russell Microcap Value Benchmark Index - marketscreener.com
NextCure, Inc.(NasdaqGS: NXTC) added to Russell 3000E Index - marketscreener.com
NextCure, Inc.(NasdaqGS: NXTC) added to Russell Microcap Index - marketscreener.com
Price to book forward of NextCure, Inc. – NASDAQ:NXTC - TradingView
Enterprise value to EBIT forward of NextCure, Inc. – NASDAQ:NXTC - TradingView
NextCure, Inc.(NasdaqGS: NXTC) added to Russell 3000E Value Benchmark - marketscreener.com
NextCure, Inc. Actuals & Estimates (NASDAQ:NXTC) - TradingView
NextCure, Inc. Actuals & Estimates (FWB:2US0) - TradingView
NextCure Inc (NXTC) Valuation: PE, PB & Fair Value Analysis - TradingKey
NXTC Forecast — Price Target — Prediction for 2027 - TradingView
NextCure, Inc. Actuals & Estimates (BOATS:NXTC) - TradingView
2US0 Forecast — Price Target — Prediction for 2027 - TradingView
NextCure Shareholders Approve Expanded Omnibus Incentive Plan - TipRanks
NextCure (NASDAQ: NXTC) shareholders back amended 2019 incentive plan and director slate - Stock Titan
NextCure Inc (NXTC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
NextCure (NXTC) director receives 2,340 options at $2.02 strike - Stock Titan
0.80%
2.11%
大文字化:
|
ボリューム (24 時間):